| [1] |
. Biomed Pharmacother，2020，124：109821.
|
| [2] |
Rohaan MW，Wilgenhof S，Haanen JBAG. Adoptive cellular therapies：the current landscape［J］. Virchows Arch，2019，474（4）：449-461.
|
| [3] |
Xie GZ，Dong H，Liang Y，et al. CAR-NK cells：a promising cellular immunotherapy for cancer［J］. eBioMedicine，2020，59：102975.
|
| [4] |
Oelsner S，Friede ME，Zhang CC，et al. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma［J］. Cytotherapy，2017，19（2）：235-249.
|
| [5] |
Zhang JG，Zheng HF，Diao Y. Natural killer cells and current applications of chimeric antigen receptor-modified NK-92 cells in tumor immunotherapy［J］. Int J Mol Sci，2019，20（2）：317.
|
| [6] |
Wang D，Tai PWL，Gao GP. Adeno-associated virus vector as a platform for gene therapy delivery［J］. Nat Rev Drug Discov，2019，18（5）：358-378.
|
| [7] |
De Haan P，Van Diemen FR，Toscano MG. Viral gene delivery vectors：the next generation medicines for immune-related diseases［J］. Hum Vaccines Immunother，2021，17（1）：14-21.
|
| [8] |
Naeimi Kararoudi M，Likhite S，Elmas E，et al. Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV［J］. Cell Rep Methods，2022，2（6）：100236.
|
| [9] |
Halbert CL，Alexander IE，Wolgamot GM，et al. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells［J］. J Virol，1995，69（3）：1473-1479.
|
| [10] |
Wang DX，Zhou QG，Qiu X，et al. Optimizing rAAV6 transduction of primary T cells for the generation of anti-CD19 AAV-CAR-T cells［J］. Biomed Pharmacother，2022，150：113027.
|
| [11] |
Gao GP，Vandenberghe LH，Alvira MR，et al. Clades of adeno-associated viruses are widely disseminated in human tissues［J］. J Virol，2004，78（12）：6381-6388.
|
| [12] |
Ellis BL，Hirsch ML，Barker JC，et al. A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with nine natural adeno-associated virus （AAV1-9） and one engineered adeno-associated virus serotype［J］. Virol J，2013，10：74.
|
| [13] |
Westhaus A，Cabanes-Creus M，Rybicki A，et al. High-throughput in vitro，Ex vivo，and in vivo screen of adeno-associated virus vectors based on physical and functional transduction［J］. Hum Gene Ther，2020，31（9/10）：575-589.
|
| [14] |
Mingozzi F，High KA. Immune responses to AAV in clinical trials［J］. Curr Gene Ther，2011，11（4）：321-330.
|
| [15] |
Rambhai HK，Ashby FJ III，Qing KY，et al. Role of essential metal ions in AAV vector-mediated transduction［J］. Mol Ther Methods Clin Dev，2020，18：159-166.
|
| [16] |
Chandler LC，Yusuf IH，McClements ME，et al. Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy［J］. Int J Mol Sci，2020，21（14）：4972.
|
| [17] |
Yang H，Qing KY，Keeler GD，et al. Enhanced transduction of human hematopoietic stem cells by AAV6 vectors：implications in gene therapy and genome editing［J］. Mol Ther Nucleic Acids，2020，20：451-458.
|
| [18] |
Qing K，Wang XS，Kube DM，et al. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression［J］. Proc Natl Acad Sci U S A，1997，94（20）：10879-10884.
|
| [19] |
Akiyama T，Ishida J，Nakagawa S，et al. Genistein，a specific inhibitor of tyrosine-specific protein kinases［J］. J Biol Chem，1987，262（12）：5592-5595.
|
| [20] |
Mukund V，Mukund D，Sharma V，et al. Genistein：its role in metabolic diseases and cancer［J］. Crit Rev Oncol，2017，119：13-22.
|
下载:
